Skip to content
2000
Volume 9, Issue 8
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

In light of emerging interest in the relevance of c-Jun NH2-terminal protein kinase 3 (JNK3) as a promising drug target, we describe here an advanced non-radioactive immunosorbent JNK3 activity assay that is applicable for routine screening of small molecule ATP-competitive enzyme inhibitors. We modified and established a JNK3/ATF-2 protocol based on our previously described p38 MAPK method [1] for a substratebound non-radioactive procedure that represents a convenient alternative to conventional radioactive protein kinase assays. The objective of the present study was to validate these conditions by using the reference compounds SP600125 and SB203580 to achieve comparable IC50 results to published data. Furthermore, an IC50 for staurosporine was determined. The protocol we describe here represents an accessible and robust screening assay for JNK3 inhibitors.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/138620706778249721
2006-09-01
2025-07-10
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/138620706778249721
Loading

  • Article Type:
    Research Article
Keyword(s): Non-radioactive immunosorbent JNK3 assay; SB203580; SP600125; staurosporine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test